zanubrutinib
beigene,abbvie
['zanubrutinib', 'brukinsa', 'lymphoma', 'abbvie', 'beigene']
beigene announced that it will release the latest research data on brukinsa (zanubrutinib) at the 17th international conference on malignant lymphoma which is held in lugano, switzerland from june 13-17. beigene's brukinsa was accused of infringement by . 
Bringing you the latest news on tech, financial, and EV companies in China.